SOD2 and triple-A syndrome: To accomplish this objective, we employ a peptide-nucleic acid nanoplatform 23 to effect efficient overexpression of SOD2 in aortic tissues to explore the exact contribution of this antioxidant enzyme to AAA pathogenesis using two different experimental models.